Keyphrases
Pediatric Patients
100%
Body Composition
100%
Rickets
100%
X-linked Hypophosphatemia
100%
Cardiometabolic Health
100%
Burosumab
100%
Severity Score
57%
Appendicular Skeletal muscle Mass
57%
Bioelectrical Impedance Analysis
42%
Fat-free Mass
42%
Growing child
28%
Fat Mass
28%
Muscle-to-fat Ratio
28%
Monoclonal Antibody
14%
Comorbidity
14%
Recombinant
14%
Life Studies
14%
Healing
14%
Young Age
14%
Blood Pressure
14%
Age-adjusted
14%
Laboratory Evaluation
14%
Pediatric
14%
Pain Reduction
14%
Reference Curve
14%
Body Fat Percentage
14%
Physique
14%
Phosphate Levels
14%
Bowing
14%
Lean Body Mass
14%
Body Composition Parameters
14%
Fibroblast Growth Factor 23 (FGF23)
14%
Reduced muscle Mass
14%
Medicine and Dentistry
Pediatrics Patient
100%
Rickets
100%
X Linked Hypophosphatemic Rickets
100%
Burosumab
100%
Skeletal Muscle
57%
Bioelectrical Impedance Analysis
42%
Blood Pressure
14%
Pediatrics
14%
Monoclonal Antibody
14%
Anthropometry
14%
Lean Body Weight
14%
Fibroblast Growth Factor 23
14%
Body Fat Percentage
14%
Comorbidity
14%
Biochemistry, Genetics and Molecular Biology
Rickets
100%
Body Composition
100%
X-Linked Hypophosphatemia
100%
Skeletal Muscle
57%
Fat Free Mass
42%
Bioelectrical Impedance Analysis
42%
Fat Mass
28%
Phosphate Blood Level
14%
Blood Pressure
14%
Monoclonal Antibody
14%
Body Fat
14%
Lean Body Weight
14%
Fibroblast Growth Factor 23
14%
Comorbidity
14%
Immunology and Microbiology
Body Composition
100%
Burosumab
100%
Skeletal Muscle
66%
Fat Free Mass
50%
Muscle
50%
Fat Mass
33%
Monoclonal Antibody
16%
Blood Pressure
16%
Leg
16%
Body Fat
16%
Phosphate Blood Level
16%
Fibroblast Growth Factor 23
16%
Lean Body Weight
16%
Comorbidity
16%